Literature DB >> 1679662

Influence of nebivolol on the cardiovascular hemodynamics during postural changes and isometric exercise.

D Duprez1, R Lefebvre, T De Backer, P De Sutter, J Trouerbach, D L Clement.   

Abstract

Nebivolol (R67555), a drug with beta 1 receptor antagonizing properties, was administered once daily (5 mg) for 7 days in 10 healthy volunteers. The hemodynamic parameters were measured noninvasively during postural changes (supine, sitting, standing) and during isometric handgrip at 50% maximal voluntary contraction, before and 3, 8, and 23 hours after the first nebivolol intake of 5 mg; the same measurements were done 23 hours after the last intake. Nebivolol lowered arterial blood pressure acutely and chronically due to a decrease in heart rate and cardiac output. The stroke volume seemed to be preserved, while the total peripheral vascular resistance did not change. Nebivolol did not change the orthostatic responses, except that the absolute value was lowered. Nebivolol was unable to prevent the blood pressure increase during isometric handgrip. However, this blood pressure increase was obtained by an increase in the total peripheral vascular resistance and not by an increase in the cardiac output, as observed during control measurements before nebivolol intake.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1679662     DOI: 10.1007/bf03029745

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  21 in total

1.  Vascular responses in forearm and calf to contralateral static exercises.

Authors:  D A Duprez; L K Essandoh; P M Vanhoutte; J T Shepherd
Journal:  J Appl Physiol (1985)       Date:  1989-02

2.  The receptor binding profile of the new antihypertensive agent nebivolol and its stereoisomers compared with various beta-adrenergic blockers.

Authors:  P J Pauwels; W Gommeren; G Van Lommen; P A Janssen; J E Leysen
Journal:  Mol Pharmacol       Date:  1988-12       Impact factor: 4.436

3.  Autonomic mechanisms in hemodynamic responses to isometric exercise.

Authors:  C E Martin; J A Shaver; D F Leon; M E Thompson; P S Reddy; J J Leonard
Journal:  J Clin Invest       Date:  1974-07       Impact factor: 14.808

4.  Hemodynamic effects of acute and prolonged beta-adrenergic blockade in essential hypertension.

Authors:  L Hansson; A J Zweifler; S Julius; S N Hunyor
Journal:  Acta Med Scand       Date:  1974 Jul-Aug

5.  Beta-blockers, autoregulation, and experimental design.

Authors:  P I Korner
Journal:  Hypertension       Date:  1984 Mar-Apr       Impact factor: 10.190

6.  Direct and noninvasive evaluation of the cardiovascular response to isometric exercise.

Authors:  J F Perez-Gonzales; N B Schiller; W W Parmley
Journal:  Circ Res       Date:  1981-06       Impact factor: 17.367

7.  Effect of different degrees of tilt on cardiac output, heart rate, and blood pressure in normal man.

Authors:  J Tuckman; J Shillingford
Journal:  Br Heart J       Date:  1966-01

8.  Effect of intravenous propranolol on the systemic circulatory response to sustained handgrip.

Authors:  H R MacDonald; R P Sapru; S H Taylor; K W Donald
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

9.  Presynaptic muscarinic receptors inhibiting endogenous noradrenaline release in the portal vein of the freely moving rat.

Authors:  R Remie; R P Coppes; J Zaagsma
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

10.  Haemodynamic responses to static and dynamic handgrip before and after autonomic blockade.

Authors:  S F Lewis; W F Taylor; B C Bastian; R M Graham; W A Pettinger; C G Blomqvist
Journal:  Clin Sci (Lond)       Date:  1983-06       Impact factor: 6.124

View more
  4 in total

1.  Influence of chronic kidney disease and haemodialysis treatment on pharmacokinetics of nebivolol enantiomers.

Authors:  Daniel V Neves; Vera L Lanchote; Miguel Moysés Neto; José A Cardeal da Costa; Carolina P Vieira; Eduardo B Coelho
Journal:  Br J Clin Pharmacol       Date:  2016-04-07       Impact factor: 4.335

Review 2.  Nebivolol in the management of essential hypertension: a review.

Authors:  W McNeely; K L Goa
Journal:  Drugs       Date:  1999-04       Impact factor: 9.546

3.  Blood pressure-lowering effect of nebivolol in hypertensive patients with type 2 diabetes mellitus: the YESTONO study.

Authors:  Andre C Schmidt; Christine Graf; Klara Brixius; Juergen Scholze
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

4.  Comparison of lisinopril and nitrendipine on the pulsatility index in mild essential arterial hypertension.

Authors:  D Duprez; M De Buyzere; F Brusselmans; A Maas; D L Clement
Journal:  Cardiovasc Drugs Ther       Date:  1992-08       Impact factor: 3.727

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.